We hear from Jonny Acheson and Clare Addison, two healthcare professionals based in England who have decided to step back from their hospital roles during the Covid-19 pandemic, about why the UK’s National Health Service (NHS) will “never be the same again”
How has the Covid-19 pandemic affected you as NHS
workers who are living with Parkinson’s?
Clare Addison, surgical matron: It’s changed my
role completely. Having Parkinson’s doesn’t mean you have an increased risk of
getting Covid-19 but if you do get it, you will likely have a slower recovery
path, meaning you could deprive someone else of valuable medical attention. We
need to be socially responsible to enable resources for those who need it. So,
after hard conversations with my managers, it was clear that I needed to work
It has been challenging for me to accept that I need to
step aside from being a healthcare professional and be at home. Being in a
senior position, people look up to me for guidance and leadership – so to take
myself away from that has been difficult.
Jonny Acheson, A&E consultant: When the guidance came out about people with Parkinson’s having an increased risk, I had to decide what’s best for me as a person with Parkinson’s versus as a trained healthcare professional. Whatever your role is in the NHS, if you are living with Parkinson’s or any high-risk condition, you are torn between what your heart says and what your mind says because you’re trained to deliver a service.
I told my team that someone needs to make this decision
for me and that’s what they did.
I’m currently trying to give support from a distance, such
as offering telephone support for staff. Team members can ring me whenever they
are struggling at work or need to talk. Although we are self-isolating, we’re
not cut off from the service and our colleagues. I’ve been drawing some NHS
sketches for my team to show my support through pictures as a way of raising
Can you give an insight into how the pandemic is
affecting NHS workers?
Jonny: It is unprecedented. We’ve had SARS, swine
flu and bird flu, but we’ve never had anything like this before and I don’t
think we ever will. There’s anxiety about how quickly this disease gets people
and it will unfortunately cause many deaths.
The NHS has gone into a different gear and barriers that
were once there are suddenly disappearing. Everyone has gone into the mode of ‘we
can do this, we have to do this, and we will do this’. I went to Sainsbury’s supermarket
this morning and people were clapping for me. In times of crisis, people really
do get behind the NHS.
Clare: There has been a lot of staff refresher training, staff moving to different areas that are in need and adjusting to the new ways of working. What has been incredible is people’s willingness to adapt – you can see they are frightened and anxious but they’re just getting on with it. Covid-19 will change the NHS forever, some of our old and convoluted processes have gone and I don’t see how they will come back. People’s skillsets are going to have been refreshed and broadened.
What would you say to people in the Parkinson’s
community that may be struggling physically or emotionally?
Jonny: There is currently an information overload, so if you want to keep up-to-date with coronavirus news, look at vetted sources. I’ve turned notifications off on my devices to give myself some headspace. I don’t think it is helpful to try and predict what is going to happen with Covid-19, instead take each day as it comes and try to live the best you can. Also, keep exercising and make sure you are finding other ways to socialise while socially distancing.
Clare: My mum has Parkinson’s and she told me on a
Skype call, “I need you to know that I don’t want to go to hospital, and I am
happy to die alone”. That’s a really hard conversation to have with your mother
but actually it’s a helpful conversation in some respects because it shows
she’s thinking about it.
How does it make you feel to be part of the NHS during
Clare: Massively proud. Although it is frustrating
not being in the hospital, we are both doing our bit in other ways. It’s
amazing seeing everyone coming together – those who are just starting out,
people coming back from retirement and those volunteering. There are definitely
struggles to come but there are some positives too.
Jonny: It’s brilliant. This is showing talent and
skillsets in workers that we have never seen before, coming out of their shells
and becoming leaders. Every time you pick up the badge and see NHS, it feels
very symbolic – the NHS won’t be the same again.
Jonny Acheson is an A&E consultant at the University Hospitals of Leicester and works in University of Leicester Medical School in Leicester, UK. Since his Parkinson’s diagnosis in 2016, his role changed from working on the frontline to working mainly in observation wards in the hospital.
Clare Addison is a matron for surgery at Surrey and Sussex Healthcare NHS Trust and is the co-lead of the Parkinson’s UK Excellence Network for the south east of England. Clare was diagnosed with Parkinson’s in 2016 and has a clinical background as a neuroscience specialist nurse.
How have you been affected by the coronavirus?
We will be doing all we can to share useful information about Covid-19 with you as the situation develops – and we need your help. To share your experience or tell us the topics you want Parkinson’s Life to cover during the pandemic, please leave a comment or email firstname.lastname@example.org.
For more information about Parkinson’s and coronavirus please visit the EPDA website.
How singing can help people manage symptoms of Parkinson’s
3 days ago
Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests
A new study by researchers in the US has found evidence that chemicals in diesel exhaust fumes can damage brain cells – and potentially increase the risk of Parkinson’s. As part of the study – published in ‘Toxicological Sciences’ – researchers tested the effects of diesel exhaust fumes on zebrafish, as their neurons interact in a similar way to those of humans. The researchers found that after being exposed to the chemicals, the zebrafish had fewer cells that dispose of toxic build-up of the protein alpha-synuclein, which occurs in Parkinson’s. The researchers replicated the experiment with cultured human cells and found similar results. Dr Jeff Bronstein, a professor of neurology at the University of California, Los Angeles (UCLA), US, said: “Overall, this report shows a plausible mechanism of why air pollution may increase the risk of Parkinson’s disease.”
Can Covid-19 increase the risk of developing Parkinson’s?
Parkinson’s could be caused or modulated by infections like Covid-19, a new study suggests – though more evidence is needed to draw a definitive conclusion. As part of the study, researchers from the Federal University of São Paulo, Brazil, drew on previous findings to support their hypothesis. For example, studies in mice have found that infection with some strains of influenza could cause neural changes similar to those in Parkinson’s. Furthermore, people born during or around the 1918 influenza pandemic were over twice as likely to develop Parkinson’s than those born in the decades before or after. Patrik Brundin, co-editor-in-chief of the Journal of Parkinson’s Disease, said that while it’s “too early to know what the long-term consequences of Covid-19 will be on the brain, the clinical psychiatry and neurology research communities definitely need to be vigilant in monitoring how those who recover from moderate and severe Covid-19 fare in…
New Parkinson’s trial platform could “dramatically speed up the search for a cure”
Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure. This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system. Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions. Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”. She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”